Albert H. Kim
@AlbertHKimMDPhD
Followers
3K
Following
4K
Media
54
Statuses
492
Director, The Brain Tumor Center, @WashUBTC @WashUNeurosurg @WUSTLmed @BarnesJewish @SitemanCenter WashU Medicine
Saint Louis, MO
Joined April 2018
Congrats to @JulieSilverst10, Medical Director-WashU Pituitary Center, and team @WashuMedBTC on randomized trial that definitively shows fluid restriction after endoscopic endonasal surgery for pituitary tumors decreases the most common post op complication. Neuro-Oncology now!
2
3
36
Please check out our collaborative meningioma paper with @akashjp330 helmed by @BhuvicP @S__Pugazenthi on the molecular basis of radiation resistance in necrotic grade 2 meningiomas. Great job, team!
academic.oup.com
AbstractBackground. World Health Organization Grade 2 meningiomas (G2Ms) often recur and resist therapies. Grade 2 meningiomas with histopathological necro
0
4
35
Congrats to @HaoChen_neuro and the team on his paper on Hao-Fountain syndrome. A fantastic collaboration with @AzadBonni and Cole Ferguson. @WashUNeurosurg
https://t.co/pEkLzukm9P
1
2
31
.@MattIshahak and team, including @JeffreyRMillman & @AlbertHKimMDPhD, developed engineered #glioblastoma (GBM) #organoids harboring GBM subtype-specific oncogenic mutations to study the underlying transcriptional regulation of tumor progression. 👉 https://t.co/EZciIZYeyf
0
6
18
What makes some #meningiomas more aggressive and harder to treat than others? A Patel @akashjp330, @AlbertHKimMDPhD, @KlischTiemo, @S__Pugazenthi, @CollinEnglish96, @akdes et al have answers. @ScienceAdvances @bcmhouston @WashUNeurosurg @BCMNeurosurgery
https://t.co/tEHxVCTHN9
1
10
19
Excited, our collaboration with @WashUNeurosurg to look at rare but devastating multiply recurrent meningiomas is out! @ScienceAdvances @BCMNeurosurgery @BCMFromtheLabs @BCMCancerCenter @AlbertHKimMDPhD @KlischTiemo @S__Pugazenthi @CollinEnglish96 @akdes
https://t.co/F9a3Z2QeHH
science.org
Clinical and mutiomic analysis reveals key biomarkers and evolution of multiply recurrent meningiomas.
2
8
51
Today is World Brain Tumor Day, an opportunity to highlight the Brain Tumor Center at Siteman and the exceptional @WUSTLmed physicians and researchers who provide exceptional care grounded in cutting-edge research and clinical trials. Learn more: https://t.co/U7A8U5Cucy
0
5
18
Great anterolateral and endoscopic endonasal approach dissections by trainees! Looking forward to @BhuvicP as a skull base colleague. @WashuBTC
That’s a wrap - “final” hands-on skull base course for our residents led by @AlbertHKimMDPhD and soon-to-be faculty @BhuvicP. We’ll be moving into a brand new surgical education lab in July. @JOsbunMDxCV
@DMathios_MD
@jstones50 Nyssa Farrell @WashUNeurosurg
@WUSTL_ENT
0
1
30
The #BrainTumorCenter seminar series welcomes Christine Brown, PhD, from @cityofhope as she discusses "CAR T Cells for #Glioblastoma. Join us in Moore Auditorium on 5/1 at 8:30 a.m. for breakfast & conversation. @SitemanCenter
0
5
12
The #BrainTumorCenter seminar series is back! Join us on 4/3 at 8:30 a.m. CST for a talk by Aaron Diaz, PhD (@diazlaboratory) about single-cell studies of #braintumor heterogeneity. @SitemanCenter @WUSTLmed
0
3
14
Repetitive sequences make up much of the human genome and have been implicated in #cancer development. In the latest edition of @ScienceMagazine, Dr. Dimitrios Mathios (@DMathios_MD) and colleagues (1/2)
1
2
15
#DivisionOfNeurotech @WashUNeurosurg Congrats all!!
Hong Chen, PhD (@ChenUltrasound) & team developed a quality assurance protocol to ensure their guided #focusedultrasound device and treatment is safe and functions consistently. @leuthardt @WashUBME Learn more.: https://t.co/YdvCvrQ04u
0
1
20
So proud of our trainee and now faculty colleague, @BhuvicP, on this collaborative study with @sahm_lab on pituitary carcinoma @NASBSorg meeting. @WashuBTC @WashUNeurosurg
2
2
39
Too fun collaborating with you, my friend. Lots of hypotheses to follow up on from our work! @BCMNeurosurgery @WashuBTC
Exciting results from our #collaboration with @AlbertHKimMDPhD on vestibular schwannomas! An injury-like state is associated with larger tumors and recruit myeloid cells. https://t.co/7mjcKgXUcv
@NatureComms @BCMNeurosurgery @alexdsweeney
0
0
27
In sum, many advances in our understanding of these common peripheral nervous system tumors, and some new techniques with broad relevance ! Exhilarating to work with @VasuLabUCSF @sjohnliu @TimCaseyClyde @AlbertHKimMDPhD and many others on these papers! @NeurosurgUCSF . 5/5
0
1
9
Third, @LabRaleigh shows that epigenetic reprogramming shared the cellular landscape of schwannomas, and reports a novel function genomic technique for single-nuclei RNA/ATAC/CRISPRi-perturbation sequencing (snARC-seq). 4/5
1
1
6
Second, @AlbertHKimMDPhD shows that vestibular schwannoma cells resemble a nerve injury-like state. 3/5
nature.com
Nature Communications - Vestibular schwannomas are benign tumours which can lead to neurological symptoms and morbidity. Here, the authors use single cell RNA-seq and ATAC-seq to identify Schwann...
1
4
16
First, @LabRaleigh shows that functional interactions between neurofibromatosis tumor suppressors underlies Schwann cell tumor de-differentiation and treatment resistance, revealing new therapeutic strategies for resistant tumors. 2/5
1
1
3
VERY happy to share THREE papers exploring the genomic, biochemical, and cellular architecture of Schwann cell tumors published in @NatureComms today from @LabRaleigh members @sjohnliu and @TimCaseyClyde, from former lab member @VasuLabUCSF, and from @AlbertHKimMDPhD! 1/5
3
13
58
Thrilled about this preprint article from Hao Chen & Albert Kim, MD, PhD about USP7 and Hao-Fountain syndrome! You guys had me at "a novel p53-independent ubiquitin signaling pathway." https://t.co/yxXspKNYrw
@AlbertHKimMDPhD @WUSTLmed #USP7 #HaoFountainsyndrome @FoundationUSP7
1
3
8